
Amgen launches an AbbVie Humira biosimilar in the U.S.
By Sam Boughedda After a dip earlier in the session, AbbVie (NYSE:ABBV) shares are now slightly up on the day, holding steady, despite Amgen (NASDAQ:AMGN) announcing AMJEVITA, a biosimilar...
By Sam Boughedda After a dip earlier in the session, AbbVie (NYSE:ABBV) shares are now slightly up on the day, holding steady, despite Amgen (NASDAQ:AMGN) announcing AMJEVITA, a biosimilar...
Investing.com - Coherus BioSciences reported on Tuesday third quarter {{erl-15719||earnings that missed analysts' forecasts and revenue that fell short of expectations. Coherus BioSciences...
Coherus BioSciences (CHRS) reported Q3 EPS of ($0.96), $0.22 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $45.4 million versus the consensus estimate of...
* Launch in coming weeks * Peak sales of $554 mln in 2022 - analyst * Mylan shares up 5.2 pct, Amgen down 1.7 pct after market (Adds analyst comment, updates shares) By Tamara...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Industrials, Financials and Technology sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Technology, Basic Materials and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
* Mizuho downgrades Apple shares * S&P tech sector set for worst 2-day drop since September * Energy stocks, banks lead S&P gainers * Indexes down: Dow 0.29 pct, S&P 0.34 pct,...
* Apple set to open at 6-week low of $145.35 * Big tech stocks also in the red * Energy stocks, banks lead S&P gainers * Indexes down: Dow 0.14 pct, S&P 0.19 pct, Nasdaq 0.74 pct...
* Apple set to open at 6-week low of $145.35 * Big tech stocks also in the red * Indexes down: Dow 0.08 pct, S&P 0.21 pct, Nasdaq 1.01 pct (Updates to open) By Yashaswini...
* Apple set to open at 6-week low of $145.35 * Apple suppliers, big tech stocks also in the red * Fed to kick off interest rate meeting on Tuesday * Futures down: Dow 18 pts, S&P 4...
* Futures down: Dow 41 pts, S&P 6.75 pts, Nasdaq 48.75 pts By Yashaswini Swamynathan June 12 (Reuters) - U.S. stock index futures were lower on Monday, with Nasdaq futures taking the...
* Bank stocks fall; gold prices, VIX shoot up * Dow, S&P below 50-day DMA for first time since April * S&P suffers largest gap down since March 2009 * Indexes down: Dow 1.24 pct,...
* Bank stocks fall; gold prices, VIX shoot up * Dollar drops to lowest level since November * Dow, S&P below 50-day DMA for first time since April * Target up on smaller drop in...
* Bank stocks fall; gold and VIX shoot up * Target up on smaller drop in comparable sales * Indexes down: Dow 0.89 pct, S&P 0.86 pct, Nasdaq 1 pct (Updates to open) By Yashaswini...
* Dollar down, erases post-election gains * Bank stocks fall; gold and VIX futures rise * Target up on smaller drop in comparable sales * Futures down: Dow 106 pts, S&P 13 pts, Nasdaq...
* Futures down: Dow 80 pts, S&P 9.5 pts, Nasdaq 18 pts By Yashaswini Swamynathan May 17 (Reuters) - U.S. stock index futures tumbled on Wednesday amid fears that a fresh controversy...
* April consumer prices record biggest gain in 3 years * Home Depot falls; biggest drag on Dow, S&P * Indexes down: Dow 0.56 pct, S&P 0.51 pct, Nasdaq 0.57 pct (Adds details,...
(Adds details) Jan 11 (Reuters) - Baxalta Inc and Coherus Biosciences Inc CHRS.O said their experimental biosimilar of Amgen Inc 's AMGN.O arthritis drug Enbrel met the main goal in a...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.